Free Trial

P3 Health Partners Inc. (NASDAQ:PIII) Short Interest Down 23.4% in October

P3 Health Partners logo with Medical background

P3 Health Partners Inc. (NASDAQ:PIII - Get Free Report) was the recipient of a significant drop in short interest in October. As of October 31st, there was short interest totalling 957,100 shares, a drop of 23.4% from the October 15th total of 1,250,000 shares. Approximately 1.4% of the shares of the company are short sold. Based on an average daily volume of 657,700 shares, the short-interest ratio is currently 1.5 days.

P3 Health Partners Trading Up 9.1 %

Shares of P3 Health Partners stock traded up $0.02 on Friday, reaching $0.23. The stock had a trading volume of 887,485 shares, compared to its average volume of 628,607. The business's 50 day moving average is $0.40 and its two-hundred day moving average is $0.51. The company has a current ratio of 0.53, a quick ratio of 0.69 and a debt-to-equity ratio of 1.11. P3 Health Partners has a 1 year low of $0.20 and a 1 year high of $1.78.

Insider Transactions at P3 Health Partners

In related news, major shareholder Pacific Founders Ugp I. Chicago acquired 80,000 shares of the company's stock in a transaction that occurred on Wednesday, September 11th. The shares were acquired at an average price of $0.56 per share, with a total value of $44,800.00. Following the acquisition, the insider now owns 77,025,438 shares of the company's stock, valued at approximately $43,134,245.28. This trade represents a 0.10 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders acquired 400,000 shares of company stock worth $205,600 over the last quarter. Corporate insiders own 17.86% of the company's stock.

Hedge Funds Weigh In On P3 Health Partners

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Renaissance Technologies LLC increased its stake in P3 Health Partners by 188.1% in the second quarter. Renaissance Technologies LLC now owns 111,800 shares of the company's stock valued at $50,000 after acquiring an additional 73,000 shares during the last quarter. Sanders Morris Harris LLC boosted its holdings in P3 Health Partners by 16.3% during the 2nd quarter. Sanders Morris Harris LLC now owns 142,998 shares of the company's stock valued at $64,000 after acquiring an additional 20,000 shares during the period. Geode Capital Management LLC lifted its position in P3 Health Partners by 115.2% in the third quarter. Geode Capital Management LLC now owns 1,029,259 shares of the company's stock valued at $398,000 after purchasing an additional 550,925 shares during the last quarter. Emfo LLC boosted its stake in shares of P3 Health Partners by 39.8% during the second quarter. Emfo LLC now owns 1,427,689 shares of the company's stock valued at $643,000 after purchasing an additional 406,418 shares during the period. Finally, Armistice Capital LLC purchased a new stake in shares of P3 Health Partners during the second quarter valued at approximately $3,557,000. 7.75% of the stock is currently owned by hedge funds and other institutional investors.

About P3 Health Partners

(Get Free Report)

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in P3 Health Partners right now?

Before you consider P3 Health Partners, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and P3 Health Partners wasn't on the list.

While P3 Health Partners currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for December 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines